Pharmaceutical Sales Reps not informing Doctors about promoted Drug Side-Effects in 60% of Visits

Doctors not informed of harmful effects of medicines during sales visits

Doctors not informed of harmful effects of medicines during sales visits
In Vancouver and Montreal, two-thirds of the promotional visits involved absolutely no mention of a drug’s potential harmful effects

Last month a study concerning the world of prescription drug information identified a new and potentially deadly hazard: the pharmaceutical sales rep visit. The study asked the question: When a drug sales rep has a private one-to-one conversation with a doctor, what kind of drug information does the physician actually receive? … The study found that in nearly 60 per cent of promotional visits, sales representatives failed to provide any information about common or serious side-effects of the promoted drug, and also failed to inform doctors about the types of patients who should not use the medicine…

Read Doctors not informed of harmful effects of medicines during sales visits

Read The sinister side-effects of drug marketing
by Alan Cassels, 22 Apr 2013

Breast Implants are increasing the Cancer Death Risk by 38%

Breast cancer detection and survival among women with cosmetic breast implants: systematic review and meta-analysis of observational studies

silicone-gel-breast-implant image
Cosmetic breast augmentation has become increasingly popular

Women who have breast implants and go on to have breast cancer have a 38% higher risk of dying from the disease than women who do not have implants, a new study suggests. The study  also found that women with cosmetic breast implants had a 26% increased risk of being diagnosed at a later stage of cancer than women without implants.

Read Breast Implants ‘Raise Cancer Death Risk’, Study Suggests
The Huffington Post UK,  1 May 2013

Sources: Breast cancer detection and survival among women with cosmetic breast implants: systematic review and meta-analysis of observational studies – BMJ Publishing Group Ltd, 30 April 2013